Journal of Translational Medicine · 2022 · 61 citations · 45 references
Life SciencesBiochemistryCardiologyCell SignalingInflammationLipid BiochemistryAdipose TissueCardiovascular DiseaseCholesterol BiosynthesisCholesterol MetabolismLipid MetabolismLipoprotein MetabolismAtherosclerosis Molecular MechanismsAtherosclerotic Lipid AccumulationAtherosclerotic ProgressionCholesterol EffluxIntracellular Lipid AccumulationLipid Metabolism PathwaysP38 Mitogen-activated Protein Kinase SignalingReverse Cholesterol Transport
Abstract Background Asprosin, a newly discovered adipokine, is a C-terminal cleavage product of profibrillin. Asprosin has been reported to participate in lipid metabolism and cardiovascular disease, but its role in atherogenesis remains elusive. Methods Asprosin was overexpressed in THP-1 macrophage-derived foam cells and apoE −/− mice using the lentiviral vector. The expression of relevant molecules was determined by qRT-PCR and/or western blot. The intracellular lipid accumulation was evaluated by high-performance liquid chromatography and Oil red O staining. HE and Oil red O staining was employed to assess plaque burden in vivo. Reverse cholesterol transport (RCT) efficiency was measured using [ 3 H]-labeled cholesterol. Results Exposure of THP-1 macrophages to oxidized low-density lipoprotein down-regulated asprosin expression. Lentivirus-mediated overexpression of asprosin promoted cholesterol efflux and inhibited lipid accumulation in THP-1 macrophage-derived foam cells. Mechanistic analysis revealed that asprosin overexpression activated p38 and stimulated the phosphorylation of ETS-like transcription factor (Elk-1) at Ser383, leading to Elk-1 nuclear translocation and the transcriptional activation of ATP binding cassette transporters A1 (ABCA1) and ABCG1. Injection of lentiviral vector expressing asprosin diminished atherosclerotic lesion area, increased plaque stability, improved plasma lipid profiles and facilitated RCT in apoE −/− mice. Asprosin overexpression also increased the phosphorylation of p38 and Elk-1 as well as up-regulated the expression of ABCA1 and ABCG1 in the aortas. Conclusion Asprosin inhibits lipid accumulation in macrophages and decreases atherosclerotic burden in apoE −/− mice by up-regulating ABCA1 and ABCG1 expression via activation of the p38/Elk-1 signaling pathway.
45
Vidya Kunjathoor, Maria Febbraio, Eugene A. Podrez et al. · Journal of Biological Chemistry · 2002 · 1K citations · Full text
Global and Regional Patterns in Cardiovascular Mortality From 1990 to 2013
Gregory A. Roth, Mark D. Huffman, Andrew Moran et al. · Circulation · 2015 · 905 citations · Full text